No black box warning on record for Tavalisse

As of the latest FDA labeling reviewed, Tavalisse (FOSTAMATINIB) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tavalisse medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypertension: Monitor blood pressure every 2 weeks until stable, then monthly. Manage hypertension using standard antihypertensive treatment and, if needed, interrupt, reduce or discontinue TAVALISSE. ( 5.1 ) Hepatotoxicity: Monitor LFTs monthly. If LFT levels are elevated, interrupt, reduce or discontinue TAVALISSE. ( 5.2 ) Diarrhea: Manage diarrhea with supportive meas

No black box warning on record for Tavalisse

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypertension: Monitor blood pressure every 2 weeks until stable, then monthly. Manage hypertension using standard antihypertensive treatment and, if needed, interrupt, reduce or discontinue TAVALISSE. ( 5.1 ) Hepatotoxicity: Monitor LFTs monthly. If LFT levels are elevated, interrupt, reduce or discontinue TAVALISSE. ( 5.2 ) Diarrhea: Manage diarrhea with supportive meas

Tavalisse Black Box Warning

No black box warning on record for Tavalisse

Other warnings & precautions

Tavalisse Black Box Warning

No black box warning on record for Tavalisse

Other warnings & precautions